• Home
  • About
    • At a glance
    • Strategy & Business model
    • Team
    • Acknowledgements
    • Careers
    • Licensing
    • Investor & Press
      • Corporate profile
      • Press
  • Alzheimer´s disease
    • Alzheimer´s disease
    • Figures
    • Diagnosis
    • Prevention
  • Pipeline
  • Products
    • e4Risk®
    • e4Quant
    • AD Dementia Test
    • Degenerative Dementia test
  • Services
  • Patents & Publications
  • Quality
  • Contact
Biocross.es
  • Home
  • About
    • At a glance
    • Strategy & Business model
    • Team
    • Acknowledgements
    • Careers
    • Licensing
    • Investor & Press
      • Corporate profile
      • Press
  • Alzheimer´s disease
    • Alzheimer´s disease
    • Figures
    • Diagnosis
    • Prevention
  • Pipeline
  • Products
    • e4Risk®
    • e4Quant
    • AD Dementia Test
    • Degenerative Dementia test
  • Services
  • Patents & Publications
  • Quality
  • Contact
Select Page
Biocross: a multiparametric method for the blood-based diagnosis of Alzheimer’s disease

Biocross: a multiparametric method for the blood-based diagnosis of Alzheimer’s disease

by Biocross | Mar 21, 2012 | News

Early diagnosis a key tool in the fight against disease. It is thus essential that currently available tools are continually improved. Biocross has defined 3 main objectives that will guide the direction of this project. BioCross: Método multiparamétrico para el...

Categories

  • News
  • Press release

Last News

  • Entrevista: Detectar el riesgo genético de padecer Alzheimer con un análisis de sangre
  • Detectar el riesgo genético de padecer Alzheimer con un análisis de sangre
  • El SERGAS adjudica a Biocross un proyecto de compra de innovación tecnológica enfocado a soluciones en el campo del envejecimiento
All rights reserved BIOCROSS S.L. Spanish VAT number B-84250869.